Where we are with point-of-care testing
- PMID: 25762459
- PMCID: PMC4403955
- DOI: 10.1111/jvh.12385
Where we are with point-of-care testing
Abstract
Viral hepatitis claims one million lives each year. Scaling up treatment for hepatitis B and C in resource-limited settings is not possible without access to reliable diagnostic tools. This article gives an overview of current technologies and the pipeline for easy-to-use assays for serological and virological analyses, which can be performed at the site of patient care ('point-of-care assays'). Furthermore, the utility of dried blood spots for hepatitis B and C viral load testing is discussed. In addition to simple and reliable diagnostics, there is a need for a sustainable funding scheme and generic production of antiviral drugs to reduce the burden of viral hepatitis worldwide.
Keywords: hepatitis B; hepatitis C; low-tech; resource-limited settings; viral load.
© 2015 The Authors. Journal of Viral Hepatitis Published by John Wiley & Sons Ltd.
References
-
- Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661–662. - PubMed
-
- EASL clinical practice guidelines. Management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167–185. - PubMed
-
- World Health Organization (WHO) Hepatitis C fact sheet. Available at: http://www.who.int/mediacentre/factsheets/fs164/en/ (accessed 24 October 2014)
-
- World Health Organization (WHO) 2014. Geneva WHO Guidelines for the screening, care and treatment of persons with hepatitis C infection.
-
- Cooke GS, Lemoine M, Thursz M, et al. Viral hepatitis and the Global Burden of Disease: a need to regroup. J Viral Hepat. 2013;20(9):600–601. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
